Entekavir monohidratı

Molecular Formula: C12H17N5O4 Molecular Weight: 295.294 CAS No.: 209216-23-9 It is a new type of cyclopentylguanosine anti HBV drug. Its pharmacological action is similar to that of entecavir. It is clinically suitable for the treatment of chronic hepatitis B virus inflammation with active replication of the virus, continuous elevation of serum aminotransferase ALT or liver histology showing active lesions. Description It is white or almost white powder, odorless, practically insoluble in water, in anhydrous ethanol and in heptanes, slightly soluble in methanol. Application It is a new type of cyclopentylguanosine anti HBV drug. Its pharmacological action is similar to that of entecavir. It is clinically suitable for the treatment of chronic hepatitis B virus inflammation with active replication of the virus, continuous elevation of serum aminotransferase ALT or liver histology showing active lesions. It is guanine nucleoside analogue, which has an inhibitory effect on hepatitis B virus (HBV) polymerase. Entecavir has a strong antiviral ability and low incidence of drug resistance in long-term use. It can effectively treat chronic hepatitis B, and its curative effect is better than that of lamivudine. The resistance rate of entecavir was 0 in the first year of treatment, but it was 5.8% in the first year of treatment in patients with YMDD mutation. Packing 25kgs / drum Storage： Keep the container sealed and store in a cool and ventilated warehouse. The temperature of the warehouse should not exceed 37 ℃. Shelf Life : 24 months from date of production when stored in good condition. Minimum Order One package.

E-posta adresi: info@standard-groups.com